サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)

世界の血漿市場−タイプ(免疫グロブリン、IV+SC、アルブミン、凝固因子VIII−血漿由来)、地域、国別分析(2018年度版):ビジネスチャンスおよび予測(2013〜2023)

レポート概要

本レポートは、広範なプライマリー調査(業界専門家、企業、出資者からの情報)やセカンダリー調査を通して作成され、タイプ(免疫グロブリン、IV+SC、アルブミン、凝固因子VIII−血漿由来、その他)、地域別(北米、欧州、APAC、その他)、および国別(米国、カナダ、ドイツ、フランス、イタリア、インド、日本、中国、オーストラリア、東南アジア)の分析を元に、世界の血漿市場を調査しました。

世界の血漿市場は、2018~2023年にかけて、CAGR 10.18%で勢い良く成長する見込みです。

血漿市場は、ここ数年で著しい成長を見せており、血漿由来医療製品の使用量が増えたことで成長が見込まれています。また、血漿提供、中国血漿産業の勃興、新しく特化した製品の導入、高齢者人口の増加、免疫不全、神経障害、凝固障害などの疾病に対する医療費の急増などは、将来的に市場の成長を促進するでしょう。地域別では、北米が世界の血漿市場で最大の地域シェアを占めています。北米地域の堅調な成長率を押し上げる主な要因は、分画プロセスのための大量のプラズマ源の収集です。

本レポートは、世界の血漿市場の潜在性について分析し、市場規模、シェア、成長要因についての統計や情報を提供します。また、最先端の市場戦略情報を提供し、意思決定者が健全な投資の評価を行うのに役立ちます。さらに、主な市場促進要因、課題、ビジネスチャンス、様々な企業の市場参入戦略についても取り上げます。

■調査範囲

世界市場分析(実データ:2013~2017年、予測期間:2018~2023年)
  • 血漿市場‐規模、成長、予測
  • タイプ別‐規模、数量、成長、予測
    ➣ 免疫グロブリン(IV+SC)
    ➣ アルブミン
    ➣ 凝固因子VIII(血漿由来)
地域市場分析‐北米、欧州、アジア太平洋、その他(実データ:2013~2017年、予測期間:2018~2023年)
  • 血漿市場‐規模、成長、予測
  • タイプ別‐規模、数量、成長、予測
    ➣ 免疫グロブリン(IV+SC)
    ➣ アルブミン
    ➣ 凝固因子VIII(血漿由来)
国別分析‐米国、カナダ、ドイツ、フランス、イタリア、インド、日本、中国、オーストラリア、東南アジア(実データ:2013~2017年、予測期間:2018~2023年)
  • 血漿市場‐規模、成長、予測
  • タイプ別‐規模、数量、成長、予測
    ➣ 免疫グロブリン(IV+SC)
    ➣ アルブミン
    ➣ 凝固因子VIII(血漿由来)
その他
  • 市場ダイナミクス‐促進要因、抑制要因
  • 市場動向
  • ポーターファイブフォース分析
  • 企業分析‐CSL Limited、Baxter International、Grifols S.A、Octa Pharma、Emergent Bio-solutions、Antaris Pharma、AMAG Pharma、Biota Pharma、Bio delivery Science International、Biotest A.G.

レポート詳細

目次

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Global Blood Plasma Market: Product Outlook

5. Global Blood Plasma Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
5.3 By Company Share (2017)

6. Global Blood Plasma Market Size, By Type: Breakdown (%)
6.1 Global Immunoglobulins (IV+SC) Market
6.1.1 By Value (2013-2023)
6.1.2 By Volume (2013-2023)
6.1.3 By Company Share, 2017
6.2 Global Albumin Market
6.2.1By Value (2013-2023)
6.2.2 By Volume (2013-2023)
6.2.3 By Company Share, 2017
6.3 Global FVIII (pd) Market
6.3.1 By Value (2013-2023)
6.3.2 By Volume (2013-2023)
6.3.3 By Company Share, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments

7. Global Blood Plasma Market: Regional Analysis

7.1 North America Blood Plasma Market: An Analysis
7.1.1 By Value (2013-2017)
7.1.2 By Value (2018-2023)
7.2 North America Blood Plasma Market: Country Analysis
7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023)
7.2.2 Canada Blood Plasma Market, By Value (2013-2023)

7.3 Europe Blood Plasma Market: An Analysis
7.3.1 By Value (2013-2017)
7.3.2 By Value (2018-2023)
7.4 Europe Blood Plasma Market: Country Analysis
7.4.1 Germany Blood Plasma Market, By Value (2013-2023)
7.4.2 France Blood Plasma Market, By Value (2013-2023)
7.4.3 Italy Blood Plasma Market, By Value (2013-2023)

7.5 APAC Blood Plasma Market: An Analysis
7.5.1 China Blood Plasma Market, By Value (2013-2023)
7.5.2 Japan Blood Plasma Market, By Value (2013-2023)
7.5.3 India Blood Plasma Market, By Value (2013-2023)
7.5.4 Australia Blood Plasma Market, By Value (2013-2023)
7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023)

7.6 ROW Blood Plasma Market: An Analysis
7.6.1 By Value (2013-2017)
7.6.2 By Value (2013-2023)
7.7 Global Blood Plasma Market: Market Comparison, By Regions
7.8 Global Blood Plasma Market: Market Attractiveness, By Regions

8. Global Blood Plasma Market Dynamics
8.1 Drivers
8.2 Challenges
8.3 Trends

9. Blood Plasma Market: Policy and Regulatory Landscape

10. Global Blood Plasma Market: Supply Chain Analysis

11. Porter's Five Forces Analysis

12 Company Profiles
12.1 CSL Limited
12.2 Baxter International
12.3 Grifols S.A.
12.4 Octa Pharma
12.5 Emergent Bio-solutions
12.6 Antaris Pharma
12.7 AMAG Pharma
12.8 Kedrion Biota Pharma
12.9 Bio delivery Science International
12.10 Biotest A.G.

List of Figures
Figure 1: Plasma Proteins and Diseases They Treat
Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population)
Figure 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016
Figure 5: United States Blood Plasma Collection, 2013-2016, in Million Liters
Figure 6: Number of Blood Collection Centers in United States, 2013-2016
Figure 7: United States Healthcare Expenditure, 2013-2016
Figure 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion)
Figure 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 11: Worldwide Demand for factor VIII, By Volume (in IU)
Figure 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016
Figure 13: Number of People With Hemophilia, Worldwide, By Type, 2016
Figure 14: Usage of Factor VIII (IU Per Capita)*, 2016
Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016
Figure 16: Number of People With Hemophilia, By Top 5 Countries, 2016
Figure 17: Number of Plasma Fractionation Plants, 2014
Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters)
Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands)
Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of Population)
Figure 21: Global Aged Population (Above 65), 2013-2017 (% of total)
Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total)
Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 24: Global Expected Healthcare Industry Outlook
Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 26: Key Factors Driving Global Healthcare Industry
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 28: Global Blood Plasma Market Share, By Company, 2017
Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%)
Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%)
Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion)
Figure 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion)
Figure 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons)
Figure 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons)
Figure 35: Global IVIG Market Share, By Company, 2017
Figure 36: Global Albumin Market, By Value, 2013-2017 (USD Billion)
Figure 37: Global Albumin Market, By Value, 2018-2023 (USD Billion)
Figure 38: Global Albumin Market, By Volume, 2013-2017 (Tons)
Figure 39: Global Albumin Market, By Volume, 2018- 2023 (Tons)
Figure 40: Global Albumin Market Share, By Company, 2017
Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion)
Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion)
Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units)
Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units)
Figure 45: Global FVIII (Pd) Market Share, By Company, 2017
Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion)
Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion)
Figure 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion)
Figure 49: Global Market Attractiveness, By Segments, 2023F
Figure 50: Healthcare Industry Landscape, By Selected Region
Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 53: North America population aged 65 and above, 2013-2017 (% of total)
Figure 54: United States health care expenditure per capita,2013-2016(USD)
Figure 55: Canada health care expenditure per capita,2013-2016(USD)
Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 57: USA Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 58: USA Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 59: U.S., Population ages 65 and above, 2013-2017 (% of total)
Figure 60: U.S. Blood Plasma Export To The World, 2015-2016, By Volume (In Kg)
Figure 61: United States health care expenditure,2013-2017(% of GDP)
Figure 62: Canada Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 63: Canada Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 64: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 65: Canada, Population ages 65 and above, 2012-2017 (% of total)
Figure 66: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 67: Health Expenditure, By Select Country, 2016 (% of GDP)
Figure 68: Europe Population ages 65 years and above (% of total population), 2013-17
Figure 69: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 70: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 71: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 72: Germany Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 73: Germany Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 74: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 75: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 76: France Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 77: France Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 78: France, Population Ages 65 and Above, In total Population, 2013-2017
Figure 79: Italy Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 80: Italy Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 81: Italy, Population Ages 65 and Above (% of total), 2013-2017
Figure 82: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 83: GDP Per Capita in APAC, By Selected Country, 2013 (In USD)
Figure 84: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Figure 85: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 86: Population ages 65 and above, By Select Country, 2050 (% of total)
Figure 87: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 88: China Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 89: China Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 90: China, Total Population, 2013-17 (In Billion)
Figure 91: China, GDP Growth Per Year, 2015-2019F (In %)
Figure 92: China, Share of Urban Population, 2012-2017 (In %)
Figure 93: China, Share of Urban Population, 2012-2017 (In %)
Figure 94: Japan Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 95: Japan Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 96: Japan, Consumption of IVIG, 2013-2017, (Million Vails/2.5g)
Figure 97: Plasma (Domestic Plasma) Through output by Japanese Fractionators, 2013-2017, Million Liters
Figure 98: Japan, Population ages 65 and above, 2012-2017 (% of total)
Figure 99: Japan Healthcare Expenditure Outlook (%)
Figure 100: India Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 101: India Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 102: India, Population ages 65 and above, 2013-2017
Figure 103: India, Share of Urban Population, 2012-2017 (In %)
Figure 104: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 105: India, Total Population, 2013-2023F (In Billion)
Figure 106: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 107: India, Population ages 65 and above, 2012-2017 (% total)
Figure 108: Australia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 109: Australia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 110: Australia, IG Demand, 2013- 2016 (Thousand Gram)
Figure 111: Australia, Source Plasma Collection Growth, 2013-2016 (%)
Figure 112: Australia, Population Above 65, 2013-2017 (% of Total)
Figure 113: Australia, Healthcare Expenditure, 2013- 2017 (% of GDP)
Figure 114: South-East Asia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 115: South-East Asia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 116: Population Above 65, By Selected Southeast Asian Countries, 2017 (% of Total)
Figure 117: Healthcare Expenditure, By Selected Southeast Asian Countries, 2015 (% of GDP)
Figure 118: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 119: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Figure 120: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Figure 121: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 122: Population ages 60 or above, By Select Country, 2050 (% of total)
Figure 123: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Figure 124: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 125: Middle East and North Africa, Population ages 65 and above (% of total)
Figure 126: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 127: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 128: Regional Market Comparison Chart, 2013-2023 (USD Billion)
Figure 129: Global Market Attractiveness, By Region, 2023F
Figure 130: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 131: Global Aged Population(Above 65), (% of total)
Figure 132: Male population, 2013-2017 (In Billion)
Figure 133: Number of People With Dementia (In Million)
Figure 134: Grifols Plasma Fractionation Capacity Growth (In Million Litters)
Figure 135: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 136: CSL Limited, Sales, By Business Segments, 2017 (In %)
Figure 137: CSL Limited, By Geographic Region, 2017 (In %)
Figure 138: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 139: Baxter International, By Business Segments, 2017 (In %)
Figure 140: Baxter International, By Geographic Region, 2017 (In %)
Figure 141: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 142: Grifols S.A, By Business Segments, 2017 (In %)
Figure 143: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 144: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 145: Emergent Bio-Solutions, By Geography, 2017 (In %)
Figure 146: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 147: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 148: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion)
Figure 149: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%)
Figure 150: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 151: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 152: Biotest A.G, By Geography, 2017 (In %)

発刊日

2018/10/31

体裁

PDF / 205ページ

販売価格

2,200USD

発行

Azoth Analytics

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE